ATE493651T1 - Verfahren und zusammensetzungen zur diagnose eines leberzellenkarzinoms - Google Patents

Verfahren und zusammensetzungen zur diagnose eines leberzellenkarzinoms

Info

Publication number
ATE493651T1
ATE493651T1 AT03763113T AT03763113T ATE493651T1 AT E493651 T1 ATE493651 T1 AT E493651T1 AT 03763113 T AT03763113 T AT 03763113T AT 03763113 T AT03763113 T AT 03763113T AT E493651 T1 ATE493651 T1 AT E493651T1
Authority
AT
Austria
Prior art keywords
methods
diagnosing
compositions
cell carcinoma
hcc
Prior art date
Application number
AT03763113T
Other languages
English (en)
Inventor
Michael Katze
Roger Bumgarner
Mariya Smit
Gary Rosenberg
Original Assignee
Illumigen Biosciences Inc
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Illumigen Biosciences Inc, Univ Washington filed Critical Illumigen Biosciences Inc
Application granted granted Critical
Publication of ATE493651T1 publication Critical patent/ATE493651T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03763113T 2002-07-03 2003-07-03 Verfahren und zusammensetzungen zur diagnose eines leberzellenkarzinoms ATE493651T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39398202P 2002-07-03 2002-07-03
PCT/US2003/020841 WO2004005466A2 (en) 2002-07-03 2003-07-03 Methods and compositions for diagnosing hepatocellular carcinoma

Publications (1)

Publication Number Publication Date
ATE493651T1 true ATE493651T1 (de) 2011-01-15

Family

ID=30115666

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03763113T ATE493651T1 (de) 2002-07-03 2003-07-03 Verfahren und zusammensetzungen zur diagnose eines leberzellenkarzinoms

Country Status (7)

Country Link
US (2) US7588902B2 (de)
EP (3) EP2299268A3 (de)
JP (2) JP4628098B2 (de)
AT (1) ATE493651T1 (de)
AU (1) AU2003247704A1 (de)
DE (1) DE60335553D1 (de)
WO (1) WO2004005466A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE493651T1 (de) 2002-07-03 2011-01-15 Illumigen Biosciences Inc Verfahren und zusammensetzungen zur diagnose eines leberzellenkarzinoms
CN103547280B (zh) * 2011-04-07 2017-06-09 艾弗兰纳特有限公司 用于药物组合物的巨噬细胞活化因子
MX357018B (es) * 2013-12-18 2018-06-05 Instituto Nac De Medicina Genomica Método de diagnóstico temprano de carcinoma hepatocelular.

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US393982A (en) 1888-12-04 jackson
JPS615800A (ja) * 1984-06-20 1986-01-11 Sekisui Chem Co Ltd ビタミンｄ結合蛋白質の定量法
JP2579497B2 (ja) 1987-09-07 1997-02-05 オリエンタル酵母工業株式会社 肝臓疾患診断剤
US5641747A (en) * 1994-07-25 1997-06-24 Temple University-Of The Commonwealth System Of Higher Education Treatment of osteopetrotic diseases
US7368531B2 (en) * 1997-03-07 2008-05-06 Human Genome Sciences, Inc. Human secreted proteins
AU7549498A (en) 1997-06-03 1998-12-21 Protegene Inc. Human proteins having transmembrane domains and dnas encoding these prot eins
US6552111B2 (en) 2000-12-22 2003-04-22 Eastman Kodak Company Cyclic olefin polymeric nanocomposite optical plastic article and method of making same
US20040068096A1 (en) 2001-09-21 2004-04-08 Zenta Tsuchihashi Human single nucleotide polymorphisms in organic anion transport and multi-drug resistant proteins
AU2003209340A1 (en) 2002-01-18 2003-09-02 Bristol-Myers Squibb Company Predictor sets for tyrosine kinase pathways
WO2003083046A2 (en) 2002-03-08 2003-10-09 Curagen Corporation Novel proteins and nucleic acids encoding same
ATE493651T1 (de) 2002-07-03 2011-01-15 Illumigen Biosciences Inc Verfahren und zusammensetzungen zur diagnose eines leberzellenkarzinoms
US20070162394A1 (en) * 2004-02-12 2007-07-12 Iconix, Inc. Rapid identification of message authentication
US8296245B2 (en) * 2008-01-03 2012-10-23 Kount Inc. Method and system for creation and validation of anonymous digital credentials

Also Published As

Publication number Publication date
US20100172833A1 (en) 2010-07-08
WO2004005466A3 (en) 2004-08-26
EP1540342A2 (de) 2005-06-15
EP2299268A3 (de) 2011-06-15
JP2006508335A (ja) 2006-03-09
EP2299268A2 (de) 2011-03-23
DE60335553D1 (de) 2011-02-10
EP2293065A2 (de) 2011-03-09
EP2293065A3 (de) 2011-06-15
WO2004005466A2 (en) 2004-01-15
EP1540342B1 (de) 2010-12-29
JP4628098B2 (ja) 2011-02-09
US7588902B2 (en) 2009-09-15
AU2003247704A8 (en) 2004-01-23
US20070161058A1 (en) 2007-07-12
EP1540342A4 (de) 2006-05-24
JP2011043512A (ja) 2011-03-03
AU2003247704A1 (en) 2004-01-23

Similar Documents

Publication Publication Date Title
BRPI0811210A2 (pt) Agente de formação de imagem, composição farmacêutica, métodos de preparação de um agente de formação de imagem, de formação de imagem óptica in vivo do corpo de um mamífero e de detecção, avaliação do estágio, diagnóstico, monitoração da progressão da doença ou monitoração do tratamento de câncer colorretal do corpo de um mamífero, e, kit para a preparação da composição farmacêutica.
EP1784639A4 (de) Verfahren zur herstellung gefriergetrockneter blutplättchen, gefriergetrocknete blutplättchen enthaltende zusammensetzungen und verwendungsverfahren
GB0421639D0 (en) Methods and compositions relating to alzheimer's disease
CY1110505T1 (el) Ανθρωπινα αντισωματα dr4 και χρησεις αυτων
EP1516049A4 (de) Zusammensetzungen und verfahren für die therapie und diagnose von lungenkrebs
CY1105322T1 (el) Μεθοδοι και συνθεσεις για την ανιχνευση παθολογικων συμβαντων
HUP0400904A2 (en) Use of genes as molecular markers in diagnosis of schizophrenia and diagnostic kit for the same
EP1796625A4 (de) Neue fenofibrat-formulierungen und relevante behandlungsmethoden
EP1539251A4 (de) Zusammensetzungen und verfahren zur diagnose und therapie von medizinischen erkrankungen mit angiogenese
EP1664718A4 (de) Diagnose und überwachung von hepatozellulärem karzinom
WO2006063093A3 (en) Methods for diagnosis and treatment of crohn's disease
EP1889058A4 (de) Diagnose und behandlung von endometriose
EP1608967A4 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von tumoren
ATE514087T1 (de) Glycokonjugate und ihre verwendung als potentielle impfstoffe gegen eine infektion mit shigella flexneri
ATE527377T1 (de) Erstellung von genexpressionprofilen aus ffpe- proben
ATE493651T1 (de) Verfahren und zusammensetzungen zur diagnose eines leberzellenkarzinoms
WO2009014342A3 (en) Markers and kit for diagnosis of alzheimer's disease
EP1546714A4 (de) Zusammensetzungen und verfahren zur verwendung beim abzielen auf peptide zur diagnose und therapie von krebs im menschen
DE602008004556D1 (de) Zusammensetzungen und verfahren zum nachweis von störungen in verbindung mit histamin
Sahu et al. An enigma of Gorlin–Goltz syndrome: Two cases reported in mother and daughter
CY1112440T1 (el) Απογλυκοζυλιωμενη και αποσιαλιδωμενη μακρα πεντραξινη ρτχ3
Sharma et al. Endoscopic ultrasound guided fine needle aspiration for diagnosis of pancreatic tuberculosis
WO2001092476A3 (de) In vitro-gewebetestsystem
DE602006016106D1 (de) Zusammensetzungen und verfahren zur vorhersage des ausgangs einer behandlung
Tursi Colonoscopy by nurse endoscopists: the right answer for the growing demand for colonoscopy in clinical practice?

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties